The Pharmacy and Therapeutics (P&T) Committee is an advisory board established pursuant to Executive Order D004-07. The committee performs clinical reviews of drug classes and makes recommendations which help the Department develop and manage the Medicaid Preferred Drug List (PDL).
The P&T Committee is required to consider clinical criteria such as drug safety and efficacy when making its recommendations. The committee also considers public comments and testimony related to the drug classes being reviewed or other PDL-related agenda items.
2022 Meeting Schedule and Handouts
Our meeting has been changed to virtual. The meeting link will be posted just prior to the meeting for public attendees.
1:00 p.m. - 5:00 p.m.
The Committee meets once quarterly in January, April, July, and October.
- October 4, 2022
-
MEETING HAS CHANGED TO A VIRTUAL MEETING
It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.
- Agenda / Minutes
- Preferred Drug List Drug Class Review Announcement
- July 12, 2022
-
MEETING HAS CHANGED TO A VIRTUAL MEETING
It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.
- Agenda / Minutes
- Preferred Drug List Drug Class Review Announcement
- April 12, 2022
-
MEETING HAS CHANGED TO A VIRTUAL MEETING
It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.
- Agenda / Minutes
- Preferred Drug List Drug Class Review Announcement
- January 11, 2022
-
MEETING HAS CHANGED TO A VIRTUAL MEETING
It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.
- Agenda / Minutes
- Preferred Drug List Drug Class Review Announcement
2021 Meeting Schedule and Handouts
Our meeting has been changed to virtual. The meeting link will be posted just prior to the meeting for public attendees.
1:00 p.m. - 5:00 p.m.
The Committee meets once quarterly in January, April, July, and October.
- October 5, 2021
-
MEETING HAS CHANGED TO A VIRTUAL MEETING
It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.
- July 13, 2021
-
MEETING HAS CHANGED TO A VIRTUAL MEETING
It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.
- April 13, 2021
-
MEETING HAS CHANGED TO A VIRTUAL MEETING
It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.
- January 12, 2021
-
MEETING HAS CHANGED TO A VIRTUAL MEETING
It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.
2020 Meeting Schedule and Handouts
Our meeting has a new location: 303 E. 17th Ave, Denver, Colorado 80203
1:00 p.m. - 5:00 p.m.
The Board meets once quarterly in January, April, July, and October
- October 6, 2020
-
MEETING HAS CHANGED TO A VIRTUAL MEETING
It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.
- July 14, 2020
-
MEETING HAS CHANGED TO A VIRTUAL MEETING
It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.
- April 7, 2020
-
MEETING HAS CHANGED TO A VIRTUAL MEETING
It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.
- January 7, 2020
-
MEETING WILL TAKE PLACE ON THE 11TH FLOOR IN CONFERENCE ROOMS 11ABC
-
Our Members
-
The P&T Committee consists of 7 physicians, 4 pharmacists and 2 client representatives, who are appointed by the Department's Executive Director. Review the Policies and Procedures Manual for more information on the committee's membership, duties and policies.
January 2020 - December 2021 Term
Lynn Parry, MD
Gwen Black, PharmD
Marisa Wiktor, MD
Kelet Robinson, MD
Thuy McKitrick, PharmD
Davin Patel, PharmD
January 2021 - December 2022 Term
James Feinstein, MD
Kimberley Jackson, DO
David Elwell, MD
Emily Kosirog, PharmD
Daralyn Morgenson, PharmD
-
Contact Us/Join Us
-
Program Administrator
Brittany Schock, PharmDColorado Department of Health Care Policy and Financing1570 Grant StreetDenver, CO 80203Phone: 303-866-6371Email: brittany.schock@state.co.usOpenings for New Members
Pharmacy & Therapeutics (P&T) Committee Open Positions Applicants are being accepted for the following two open positions for the P&T Committee member term ending in December 2022:
- One physician who specializes in the practice of psychiatry
- One physician who specializes in the treatment of members with disabilities
Applicants are being accepted for the following six open positions for the P&T Committee member terms January 2022 - December 2023:
- Pharmacist (2 positions)
- Specialty Physician (3 positions)
- Member Representative (1 position)
The actively practicing pharmacist, physician, or member representative shall serve two-year terms. Duties, membership and other term details can be found in the P&T Committee Policies and Procedures.
If interested in serving or know someone who would be qualified, please submit/have them submit a CV along with a completed Conflict of Interest form by October 22, 2021, to:
Colorado Department of Health Care Policy and Financing
Attn: Brittany Schock, PharmD
Fax to 303-866-3590 or email Brittany.Schock@state.co.usA CV is not required for the member representative position. A resume (or similar document) is acceptable.
Presenting Testimony
Interested parties who want to present at the meeting shall give at least 3 business days notice (by 5 p.m. MST), prior to the meeting, to Jessica Czechowski, Clinical Account Manager, by email at jlczechowski@magellanhealth.com and carbon copy Brittany Schock, PDL Pharmacist, by email at brittany.schock@state.co.us. Please see the specific deadline for testimony on the meeting agenda.
Please see the P&T Committee Policies and Procedures for both written and verbal comments.
Reasonable accommodations for the meetings will be provided upon request for persons with disabilities. Please contact the Program Administrator at least one week prior to the scheduled meeting if you need special arrangements.